ADR Ratio Change Effective

Core Viewpoint - Biodexa Pharmaceuticals PLC has announced a change in the ratio of its American Depositary Receipts (ADR), effective July 31, 2025, which will convert one ADR from representing 10,000 ordinary shares to representing 100,000 ordinary shares [2][3]. Group 1: ADR Ratio Change - The ratio change will function as a one-for-ten reverse ADR split for existing ADR holders, with the exchange occurring automatically [3]. - The previous ADRs will be cancelled, and new ADRs will be issued by JPMorgan Chase Bank, N.A., the depositary bank for the company's ADR program [3]. Group 2: Total Voting Rights - The total number of issued ordinary shares of Biodexa will remain unchanged at 61,952,308,922 shares following the ratio change [4]. - After the ratio change, there will be 619,523 ADRs outstanding [4].